Rodman & Renshaw Downgrades Athira Pharma (ATHA) to Neutral
Tweet Send to a Friend
Rodman & Renshaw analyst Elemer Piros downgraded Athira Pharma (NASDAQ: ATHA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
